Prostate Cancer

US Patent Application 20130059018 A1, Mar 7, 2013 - Phytocannabinoids in the treatment of cancer

​

Towards the use of non-psychoactive cannabinoids for prostate cancer

Pacher, Pal, et al.

British Journal of Pharmacology. 2013, 168: 76-78 (Full).

​

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells

Nithipatikom, Kasem, et al.

Endocrinology. 2012 Jan, 153(1): 29-41 (Full).

​

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

Ramos, Juan A, et al.

Indian Journal of Urology. 2012 Mar, 28(1): 9-14 (Full).

​

Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent

Sreevalasan, Sandeep, et al.

Anticancer Research: International Journal of Cancer Research and Treatment. 2011, 31: 3799-3808 (Full).

​

The endocannabinoid system in prostate cancer

Diaz-Laviada, Ines, et al.

Nature Reviews Urology. 2011 Oct, 8: 553-561 (abstract).

​

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

Browin, Iain, et al.

Carcinogenesis. 2010, 31(9): 1584-1591 (Full).

​

Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer

Fowler, Christopher, et al.

PLOS One. 2010 Dec, 5(12) (Full online article).

​

The cannabinoid R(+)methanandamide induces IL-6 secretion by prostate cancer PC3 cells

Olea-Herrero, Nuria, et al.

Journal of Immunotoxicology. 2009 Dec, 6(4): 249-256 (abstract).

​

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2

Olea-Herrero, N, et al.

British Journal of Cancer. 2009, 101: 940-950 (Full).

​

Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma

Czifra, Gabriella, et al.

Journal of Cancer Research and Clinical Oncology. 2009 Apr, 135(4): 507-514 (abstract).

​

Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8

De Petrocellis, Luciano, et al.

The Journal of Pharmacology and Experimental Therapeutics. 2008, 325(3): 1007-1015 (Full).

​

Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism

Endsley, Michael P, et al.

International Journal of Cancer. 2007 Apr 18, 121(5): 984-991 (Full).

​

Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest

Sarfaraz, Sami, et al.

The Journal of Biological Chemistry. 2006, 281: 39480-39491 (Full).

​

A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells

Kogan, Natalya, et al.

Molecular Pharmacology. 2006, 70: 51-59 (Full).

​

Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer

Sarfaraz, Sami, et al.

Cancer Research. 2005, 65: 1635-1641 (Full).

​

A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells

Nithipatikom, Kasem, et al.

Biochemical and Biophysical Research Communications. 2005 Jul 15, 332(4): 1028-1033 (abstract).

​

2-Arachidonoylglycerol: A Novel Inhibitor of Androgen Independent Prostate Cancer Cell Invasion

Nithipatikom, Kasem, et al.

Cancer Research. 2004, 64: 8826-8830 (Full).

​

Pharmacokinetics and Pharmacodynamics of Cannabinoids

Grotenhermen, Franjo, et al.

Clinical Pharmacokinetics. 2003 Apr, 42(4): 327-360 (abstract).

​

Δ9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells

Velasco, Lara, et al.

European Journal of Biochemistry. 2001 Feb, 268(3): 531-535 (Full).

​

Δ9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

Ruiz, Lidia, et al.

FEBS Letters. 1999 Sep 24, 458(3): 400-404 (Full).